TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32154876

Group type: EXPERIMENTAL
Intervention: DCD parent questionnaire (DCDQ) assessment
Number of subjects: 11814
Study: 35382856

Group type: EXPERIMENTAL
Intervention: Mosquito Shield™, a spatial repellent incorporating transfluthrin on a plastic sheet
Number of subjects: 1920

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1920
Study: 33386335

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU) every 3 months for 18 months
Number of subjects: 3046

Group type: COMPARATOR
Intervention: Placebo every 3 months for 18 months
Number of subjects: 3046

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU) with dietary calcium intake >300 mg/day
Number of subjects: 3046

Group type: COMPARATOR
Intervention: Placebo with dietary calcium intake >300 mg/day
Number of subjects: 3046

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU)
Number of subjects: 3046

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3046
Study: 32827416

Group type: EXPERIMENTAL
Intervention: Fixed orthodontic appliances (FOAs) worn for 2 to 3 years
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Fixed orthodontic appliances (FOAs) worn for 1 to 1.5 years
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (no orthodontic treatment)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Fixed orthodontic appliances (FOAs) worn for up to 1.5 years
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Fixed orthodontic appliances (FOAs) worn for more than 1.5 years
Number of subjects: 115
Study: 35672703

Group type: EXPERIMENTAL
Intervention: Intermittent screening and treatment (ISTi)
Number of subjects: 757

Group type: COMPARATOR
Intervention: Passive case detection (PCDi)
Number of subjects: 757
Study: 33136301

Group type: EXPERIMENTAL
Intervention: Tailored music listening intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 34665230

Group type: EXPERIMENTAL
Intervention: Pea protein
Number of subjects: 15

Group type: COMPARATOR
Intervention: Casein
Number of subjects: 15
Study: 34697129

Group type: EXPERIMENTAL
Intervention: Belimumab
Number of subjects: 8824

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8824
Study: 33367483

Group type: EXPERIMENTAL
Intervention: GPLEMMA method for estimating GxE heritability
Number of subjects: 500000

Group type: COMPARATOR
Intervention: Whole-genome regression approach (LEMMA)
Number of subjects: 500000
Study: 32416803

Group type: COMPARATOR
Intervention: 0% CSM (control)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 100% CSM (CSM100)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 13.46% CSM or more
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 20.18% CSM
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 20.18% and 26.91% CSM
Number of subjects: 300
Study: 35737923

Group type: EXPERIMENTAL
Intervention: Bicalutamide 150 mg daily
Number of subjects: 760

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 760
Study: 32493693

Group type: EXPERIMENTAL
Intervention: Oral roxadustat three times weekly
Number of subjects: 303

Group type: COMPARATOR
Intervention: Darbepoetin alfa injections once weekly
Number of subjects: 303
Study: 35088189

Group type: EXPERIMENTAL
Intervention: Totally stapled Kono-S anastomosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stapled ileocolic side-to-side anastomosis
Number of subjects: 0
Study: 34251730

Group type: EXPERIMENTAL
Intervention: Anti-A1 IgM
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Anti-B IgM
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: ROC analysis for anti-B IgM
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: ROC analysis for anti-A1 IgM
Number of subjects: 286
Study: 34147344

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicines (IH)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 32259260

Group type: EXPERIMENTAL
Intervention: Low-frequency repetitive transcranial magnetic stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35643391

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1084

Group type: EXPERIMENTAL
Intervention: Meta-analysis of 6 RCT
Number of subjects: 1084
Study: 33795790

Group type: EXPERIMENTAL
Intervention: Manual expression
Number of subjects: 96

Group type: COMPARATOR
Intervention: Electric pumping
Number of subjects: 96
Study: 32290490

Group type: EXPERIMENTAL
Intervention: Endurance Training (Zumba Fitness®)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Concurrent Training (Zumba Fitness® + muscle-strengthening workout)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 98
Study: 34019431

Group type: EXPERIMENTAL
Intervention: Carboplatin HIPEC (800 mg/m2 for 90 minutes)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard arm (no HIPEC)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Carboplatin HIPEC
Number of subjects: 98
Study: 33334453

Group type: EXPERIMENTAL
Intervention: Catheter Ablation (CA)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Medical Rate Control (MRC)
Number of subjects: 66
Study: 35319004

Group type: EXPERIMENTAL
Intervention: Centralized loading (weighted vest)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Peripheral loading (straight barbell)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both conditions (centralized and peripheral)
Number of subjects: 17
Study: 33986339

Group type: EXPERIMENTAL
Intervention: Knowledge of peers' gender and racial identities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Demography-agnostic networks
Number of subjects: 0
Study: 32090767

Group type: EXPERIMENTAL
Intervention: Perceived risk assessment in men
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Perceived risk assessment in women
Number of subjects: 714

Group type: COMPARATOR
Intervention: Comparison of risk perception between genders
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Regression modeling for men
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Regression modeling for women
Number of subjects: 714
Study: 35691486

Group type: EXPERIMENTAL
Intervention: Physical activity intervention designed to promote national recommendations (N=24,657)
Number of subjects: 24931

Group type: COMPARATOR
Intervention: Usual activity comparison (N=24,674)
Number of subjects: 24931

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 24931
Study: 34370319

Group type: EXPERIMENTAL
Intervention: New donor hierarchy
Number of subjects: 250

Group type: COMPARATOR
Intervention: Traditional donor hierarchy
Number of subjects: 250
Study: 32595599

Group type: EXPERIMENTAL
Intervention: High baseline CRF
Number of subjects: 5869

Group type: EXPERIMENTAL
Intervention: Improved CRF
Number of subjects: 5869

Group type: EXPERIMENTAL
Intervention: Baseline BMI
Number of subjects: 5869

Group type: EXPERIMENTAL
Intervention: Low PBF at baseline
Number of subjects: 5869

Group type: EXPERIMENTAL
Intervention: Baseline CRF
Number of subjects: 5869
Study: 35272405

Group type: EXPERIMENTAL
Intervention: Thumb-tack needles at Guanyuan (CV 4), Zusanli (ST 36), and Taiyuan (LU 9)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham thumb-tack needles at identical acupoints
Number of subjects: 50
Study: 32242272

Group type: EXPERIMENTAL
Intervention: 3D immersive informed consent (group 1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3D immersive informed consent (group 2)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional 2D radiological images (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3D immersive informed consent (group 1 and group 2)
Number of subjects: 40
Study: 33206567

Group type: EXPERIMENTAL
Intervention: On-demand ride hailing app (RHA) use to avoid DUI
Number of subjects: 123

Group type: COMPARATOR
Intervention: Alternate modes of transportation (self-driving or riding in another's car)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: RHA use influenced by friends' disapproval of DUI
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: RHA as primary mode of transportation to clubs
Number of subjects: 123
Study: 35366072

Group type: EXPERIMENTAL
Intervention: Apalutamide + ADT
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Placebo + ADT
Number of subjects: 1052
Study: 33259451

Group type: EXPERIMENTAL
Intervention: Iron isomaltoside administered intravenously over 30 minutes during surgical wound closure
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo administered intravenously over 30 minutes during surgical wound closure
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Iron isomaltoside
Number of subjects: 89
Study: 32228078

Group type: EXPERIMENTAL
Intervention: Triathlon prosthesis
Number of subjects: 125

Group type: COMPARATOR
Intervention: Kinemax prosthesis
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 125
Study: 34013992

Group type: EXPERIMENTAL
Intervention: eptinezumab 100 mg
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: eptinezumab 300 mg
Number of subjects: 1072

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1072
Study: 36054180

Group type: EXPERIMENTAL
Intervention: High IRSA (UNa 19-40 mmol/L)
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Intermediate IRSA (UNa 41-68 mmol/L)
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Low IRSA (UNa 69-139 mmol/L)
Number of subjects: 339
Study: 32144015

Group type: EXPERIMENTAL
Intervention: Snodgrass procedure (Group 1, 30 patients)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Snodgraft procedure (Group 2, 30 patients)
Number of subjects: 60
Study: 33813183

Group type: EXPERIMENTAL
Intervention: 3-hour educational workshop and one session of individual clinical instruction
Number of subjects: 105

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 105
Study: 33116101

Group type: EXPERIMENTAL
Intervention: Intrathecal 0.4ml midazolam with 0.5% 3ml bupivacaine (Group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with 0.5% 3ml bupivacaine alone (Group B)
Number of subjects: 0
Study: 35918164

Group type: EXPERIMENTAL
Intervention: Quantitative collateral score (qCS)
Number of subjects: 1813

Group type: EXPERIMENTAL
Intervention: Time to recanalization
Number of subjects: 1813

Group type: EXPERIMENTAL
Intervention: Visual collateral score (vCS)
Number of subjects: 1813

Group type: EXPERIMENTAL
Intervention: Time to CT angiography (CTA)
Number of subjects: 1813

Group type: EXPERIMENTAL
Intervention: Interaction between qCS and time to recanalization
Number of subjects: 1813
Study: 33387606

Group type: EXPERIMENTAL
Intervention: In-person pain coping skills training (PCST)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Videoconference-based pain coping skills training (PCST)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Pain severity reduction associated with education level
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Pain interference reduction associated with cancer type
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Pain interference reduction associated with marital status
Number of subjects: 178
Study: 32532354

Group type: EXPERIMENTAL
Intervention: Social Stories™ intervention delivered by school staff
Number of subjects: 278

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 278
Study: 35789220

Group type: EXPERIMENTAL
Intervention: Naloxone education and distribution tool through simulation training
Number of subjects: 21
Study: 33270499

Group type: EXPERIMENTAL
Intervention: Multilayer short-stretch bandaging (Rosidal-K®)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Adjustable compression velcro wrap (Circaid Reduction kit®)
Number of subjects: 36
Study: 32314970

Group type: EXPERIMENTAL
Intervention: mHealth intervention (motivational interview calls and SMS text messaging)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: mHealth intervention (≥50% of scheduled calls)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: mHealth intervention
Number of subjects: 164
Study: 34797180

Group type: EXPERIMENTAL
Intervention: Vacuum Sealing Drainage (VSD)
Number of subjects: 0
Study: 32098509

Group type: EXPERIMENTAL
Intervention: Protocol-compliant simulation + traditional placements (5 days of simulation prior to traditional placement)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Traditional placements
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Intention-to-treat simulation + traditional placements
Number of subjects: 325
Study: 35963935

Group type: EXPERIMENTAL
Intervention: HealthyMoms app
Number of subjects: 134
Study: 33795393

Group type: EXPERIMENTAL
Intervention: Increased coagulation factor VIII activity (FVIII)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased von Willebrand factor level (vWF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased phosphorylated fibrinopeptide A level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decreased fibrinogen level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fibrinogen and phosphorylated fibrinopeptide A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FVIII and vWF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Migraine to hemostatic measures
Number of subjects: 0
Study: 32381181

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 61
Study: 35603917

Group type: EXPERIMENTAL
Intervention: Freeze-all
Number of subjects: 619

Group type: COMPARATOR
Intervention: Fresh-embryo transfer
Number of subjects: 619
Study: 34406271

Group type: COMPARATOR
Intervention: One leg, once a week TENS application
Number of subjects: 137

Group type: COMPARATOR
Intervention: One leg, twice a week TENS application
Number of subjects: 137

Group type: COMPARATOR
Intervention: Two legs, once a week TENS application
Number of subjects: 137

Group type: COMPARATOR
Intervention: Two legs, twice a week TENS application
Number of subjects: 137
Study: 35347555

Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (2.5 g of turmeric 3×/week for 12 weeks)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study: 32631401

Group type: EXPERIMENTAL
Intervention: Obesity-related health education, physical exercise, and diet control for 1 year
Number of subjects: 948

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 948
Study: 33198491

Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 5674

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5674
Study: 33733958

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Enjoyment ratings for HIIT
Number of subjects: 28

Group type: COMPARATOR
Intervention: Enjoyment ratings for MICT
Number of subjects: 28
Study: 33440969

Group type: EXPERIMENTAL
Intervention: DLT with CDM
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Univent with CDM
Number of subjects: 120

Group type: COMPARATOR
Intervention: DLT control
Number of subjects: 120

Group type: COMPARATOR
Intervention: Univent control
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Time needed for successful intubation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Severe complications
Number of subjects: 120
Study: 32223617

Group type: EXPERIMENTAL
Intervention: Mindful Hypnotherapy (MH)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 42
Study: 34651206

Group type: EXPERIMENTAL
Intervention: 30 µg I/kg/day of iodine in oral drops given to 47 infants from their first day of life until hospital discharge
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group: 47 infants without supplements
Number of subjects: 94
Study: 33675048

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT), 8 sessions, 90 minutes each
Number of subjects: 30
Study: 35779102

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Silver-embedded occlusive dressing (control)
Number of subjects: 230
Study: 33504496

Group type: EXPERIMENTAL
Intervention: Liraglutide up to 1.8 mg/day
Number of subjects: 9340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9340
Study: 33214048

Group type: EXPERIMENTAL
Intervention: HSM
Number of subjects: 106

Group type: COMPARATOR
Intervention: SOR
Number of subjects: 106
Study: 33288468

Group type: EXPERIMENTAL
Intervention: Positive-relaxing environments
Number of subjects: 180

Group type: COMPARATOR
Intervention: Neutral environments
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Negative-stimulating environments
Number of subjects: 180

Group type: COMPARATOR
Intervention: Altered states of consciousness and suggestibility
Number of subjects: 180
Study: 33276768

Group type: EXPERIMENTAL
Intervention: Perioperative cognitive behavioral therapy (CBT) - six individual sessions, two before and four after surgery.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Perioperative education plus progressive exercise program (control group).
Number of subjects: 0
Study: 36231957

Group type: EXPERIMENTAL
Intervention: Non-cash intervention (reminding patients of free T-shirts or Kiondos) and psychosocial support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard care without non-cash incentives)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall retention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mortality and lost to follow-up rates
Number of subjects: 0
Study: 32931328

Group type: EXPERIMENTAL
Intervention: Routine surveillance and contact tracing (surge testing) events
Number of subjects: 1434

Group type: EXPERIMENTAL
Intervention: Surge testing events
Number of subjects: 1434

Group type: EXPERIMENTAL
Intervention: Participants aged 60 years or older
Number of subjects: 1434

Group type: EXPERIMENTAL
Intervention: Sleeping arrangements
Number of subjects: 1434
Study: 32920973

Group type: EXPERIMENTAL
Intervention: Refined rapeseed oil (RA) 50 g daily for 8 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Refined olive oil (OL) 50 g daily for 8 weeks
Number of subjects: 27
Study: 32037273

Group type: EXPERIMENTAL
Intervention: 30 mg/kg of methylprednisolone
Number of subjects: 29

Group type: COMPARATOR
Intervention: Saline as placebo
Number of subjects: 29
Study: 35074248

Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum
Number of subjects: 156

Group type: COMPARATOR
Intervention: Needle Fasciotomy (NF)
Number of subjects: 156
Study: 34110885

Group type: EXPERIMENTAL
Intervention: Contingent group received monetary incentives for negative breathalyzer samples.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Noncontingent group received matched incentives for samples independent of alcohol content.
Number of subjects: 36
Study: 32444152

Group type: EXPERIMENTAL
Intervention: Land-walking (LW)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Water-walking (WW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study: 36268379

Group type: EXPERIMENTAL
Intervention: 0.3 μg/kg/min remifentanil
Number of subjects: 110

Group type: COMPARATOR
Intervention: 0.1 μg/kg/min remifentanil
Number of subjects: 110
Study: 34711182

Group type: EXPERIMENTAL
Intervention: Online safety decision and planning intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Safety and empowerment strategies delivered via text only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of text and phone calls with trained advocates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care control arm
Number of subjects: 0
Study: 32841525

Group type: EXPERIMENTAL
Intervention: Actiponin (Gynostemma pentaphyllum extract)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36208471

Group type: EXPERIMENTAL
Intervention: eHealth intervention (personalized psychoeducational session + 14-day eHealth intervention)
Number of subjects: 42
Study: 33568118

Group type: EXPERIMENTAL
Intervention: 6-week psychosocial support program with oral health educational components
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 118
Study: 32988519

Group type: EXPERIMENTAL
Intervention: Chitosan oligosaccharide (COS) supplementation at 200 mg/kg
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (basal diet under normal temperature)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Heat stress group (HS) with basal diet under cycle heat stress
Number of subjects: 108
Study: 34803023

Group type: EXPERIMENTAL
Intervention: Antibiotics prior to skin incision
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Antibiotics after umbilical cord clamping
Number of subjects: 63

Group type: COMPARATOR
Intervention: Vaginal delivery (control)
Number of subjects: 63
Study: 34463415

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 2477

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 2477

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2477

Group type: EXPERIMENTAL
Intervention: Empagliflozin (both doses)
Number of subjects: 2477
Study: 33332233

Group type: EXPERIMENTAL
Intervention: Pre-fatigue PBM (Group 1)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Post-fatigue PBM (Group 2)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo PBM
Number of subjects: 35
Study: 34873781

Group type: EXPERIMENTAL
Intervention: Prolonged intermittent theta burst stimulation (piTBS; N = 19)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS (N = 20)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sham stimulation (N = 22)
Number of subjects: 61
Study: 32174361

Group type: EXPERIMENTAL
Intervention: Skeuomorphic icons
Number of subjects: 48

Group type: COMPARATOR
Intervention: Flat icons
Number of subjects: 48
Study: 35993803

Group type: EXPERIMENTAL
Intervention: Mogamulizumab
Number of subjects: 2

Group type: COMPARATOR
Intervention: Vorinostat
Number of subjects: 2
Study: 34971270

Group type: COMPARATOR
Intervention: FMI (Facility-based intervention)
Number of subjects: 153

Group type: COMPARATOR
Intervention: HMI (Home-based intervention)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 153